Global Passive Transdermal Drug Delivery Market Research Report 2021

Global Passive Transdermal Drug Delivery Market Research Report 2021

Table of Contents
1 Passive Transdermal Drug Delivery Market Overview
1.1 Product Overview and Scope of Passive Transdermal Drug Delivery
1.2 Passive Transdermal Drug Delivery Segment by Type
1.2.1 Global Passive Transdermal Drug Delivery Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Microfluidics
1.2.3 Smart Pill Technology (SPT)
1.3 Passive Transdermal Drug Delivery Segment by Application
1.3.1 Passive Transdermal Drug Delivery Sales Comparison by Application: (2021-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Passive Transdermal Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Passive Transdermal Drug Delivery Revenue 2016-2027
1.4.2 Global Passive Transdermal Drug Delivery Sales 2016-2027
1.4.3 Passive Transdermal Drug Delivery Market Size by Region: 2016 Versus 2021 Versus 2027
2 Passive Transdermal Drug Delivery Market Competition by Manufacturers
2.1 Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturers (2016-2021)
2.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Passive Transdermal Drug Delivery Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites, Area Served, Product Type
2.5 Passive Transdermal Drug Delivery Market Competitive Situation and Trends
2.5.1 Passive Transdermal Drug Delivery Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Passive Transdermal Drug Delivery Players Market Share by Revenue
2.5.3 Global Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Passive Transdermal Drug Delivery Retrospective Market Scenario by Region
3.1 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Passive Transdermal Drug Delivery Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.3.1 North America Passive Transdermal Drug Delivery Sales by Country
3.3.2 North America Passive Transdermal Drug Delivery Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.4.1 Europe Passive Transdermal Drug Delivery Sales by Country
3.4.2 Europe Passive Transdermal Drug Delivery Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Passive Transdermal Drug Delivery Market Facts & Figures by Region
3.5.1 Asia Pacific Passive Transdermal Drug Delivery Sales by Region
3.5.2 Asia Pacific Passive Transdermal Drug Delivery Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.6.1 Latin America Passive Transdermal Drug Delivery Sales by Country
3.6.2 Latin America Passive Transdermal Drug Delivery Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Passive Transdermal Drug Delivery Market Facts & Figures by Country
3.7.1 Middle East and Africa Passive Transdermal Drug Delivery Sales by Country
3.7.2 Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Passive Transdermal Drug Delivery Historic Market Analysis by Type
4.1 Global Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
4.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Type (2016-2021)
4.3 Global Passive Transdermal Drug Delivery Price by Type (2016-2021)
5 Global Passive Transdermal Drug Delivery Historic Market Analysis by Application
5.1 Global Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
5.2 Global Passive Transdermal Drug Delivery Revenue Market Share by Application (2016-2021)
5.3 Global Passive Transdermal Drug Delivery Price by Application (2016-2021)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.1.4 3M Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Actavis, Inc.
6.2.1 Actavis, Inc. Corporation Information
6.2.2 Actavis, Inc. Description and Business Overview
6.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Actavis, Inc. Product Portfolio
6.2.5 Actavis, Inc. Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer AG Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Boehringer Ingelheim GmbH
6.4.1 Boehringer Ingelheim GmbH Corporation Information
6.4.2 Boehringer Ingelheim GmbH Description and Business Overview
6.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Boehringer Ingelheim GmbH Product Portfolio
6.4.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.5 Corium International, Inc.
6.5.1 Corium International, Inc. Corporation Information
6.5.2 Corium International, Inc. Description and Business Overview
6.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Corium International, Inc. Product Portfolio
6.5.5 Corium International, Inc. Recent Developments/Updates
6.6 Echo Therapeutics, Inc.
6.6.1 Echo Therapeutics, Inc. Corporation Information
6.6.2 Echo Therapeutics, Inc. Description and Business Overview
6.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Echo Therapeutics, Inc. Product Portfolio
6.6.5 Echo Therapeutics, Inc. Recent Developments/Updates
6.7 GlaxoSmithKline plc
6.6.1 GlaxoSmithKline plc Corporation Information
6.6.2 GlaxoSmithKline plc Description and Business Overview
6.6.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline plc Product Portfolio
6.7.5 GlaxoSmithKline plc Recent Developments/Updates
6.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
6.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
6.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
6.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Product Portfolio
6.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
6.9 Mylan N.V.
6.9.1 Mylan N.V. Corporation Information
6.9.2 Mylan N.V. Description and Business Overview
6.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Mylan N.V. Product Portfolio
6.9.5 Mylan N.V. Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Novartis AG Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Noven Pharmaceuticals, Inc.
6.11.1 Noven Pharmaceuticals, Inc. Corporation Information
6.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Description and Business Overview
6.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Noven Pharmaceuticals, Inc. Product Portfolio
6.11.5 Noven Pharmaceuticals, Inc. Recent Developments/Updates
6.12 Transdermal Corp.
6.12.1 Transdermal Corp. Corporation Information
6.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Description and Business Overview
6.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Transdermal Corp. Product Portfolio
6.12.5 Transdermal Corp. Recent Developments/Updates
7 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
7.1 Passive Transdermal Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Passive Transdermal Drug Delivery
7.4 Passive Transdermal Drug Delivery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Passive Transdermal Drug Delivery Distributors List
8.3 Passive Transdermal Drug Delivery Customers
9 Passive Transdermal Drug Delivery Market Dynamics
9.1 Passive Transdermal Drug Delivery Industry Trends
9.2 Passive Transdermal Drug Delivery Growth Drivers
9.3 Passive Transdermal Drug Delivery Market Challenges
9.4 Passive Transdermal Drug Delivery Market Restraints
10 Global Market Forecast
10.1 Passive Transdermal Drug Delivery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Type (2022-2027)
10.2 Passive Transdermal Drug Delivery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Application (2022-2027)
10.3 Passive Transdermal Drug Delivery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Passive Transdermal Drug Delivery by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Passive Transdermal Drug Delivery by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Passive Transdermal Drug Delivery Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Passive Transdermal Drug Delivery Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Passive Transdermal Drug Delivery Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Passive Transdermal Drug Delivery Covered in This Study
Table 5. Global Passive Transdermal Drug Delivery Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Passive Transdermal Drug Delivery Sales Share by Manufacturers (2016-2021)
Table 7. Global Passive Transdermal Drug Delivery Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Passive Transdermal Drug Delivery Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Passive Transdermal Drug Delivery Manufacturing Sites and Area Served
Table 11. Manufacturers Passive Transdermal Drug Delivery Product Type
Table 12. Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Passive Transdermal Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Passive Transdermal Drug Delivery as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Passive Transdermal Drug Delivery Sales by Region (2016-2021) & (K Units)
Table 16. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2021)
Table 17. Global Passive Transdermal Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Passive Transdermal Drug Delivery Sales by Country (2016-2021) & (K Units)
Table 19. North America Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2021)
Table 20. North America Passive Transdermal Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2021)
Table 22. Europe Passive Transdermal Drug Delivery Sales by Country (2016-2021) & (K Units)
Table 23. Europe Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2021)
Table 24. Europe Passive Transdermal Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Passive Transdermal Drug Delivery Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Passive Transdermal Drug Delivery Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Passive Transdermal Drug Delivery Revenue Market Share by Region (2016-2021)
Table 30. Latin America Passive Transdermal Drug Delivery Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2021)
Table 32. Latin America Passive Transdermal Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Passive Transdermal Drug Delivery Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Passive Transdermal Drug Delivery Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Passive Transdermal Drug Delivery Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Passive Transdermal Drug Delivery Revenue Market Share by Country (2016-2021)
Table 38. Global Passive Transdermal Drug Delivery Sales (K Units) by Type (2016-2021)
Table 39. Global Passive Transdermal Drug Delivery Sales Market Share by Type (2016-2021)
Table 40. Global Passive Transdermal Drug Delivery Revenue (Million US$) by Type (2016-2021)
Table 41. Global Passive Transdermal Drug Delivery Revenue Share by Type (2016-2021)
Table 42. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Type (2016-2021)
Table 43. Global Passive Transdermal Drug Delivery Sales (K Units) by Application (2016-2021)
Table 44. Global Passive Transdermal Drug Delivery Sales Market Share by Application (2016-2021)
Table 45. Global Passive Transdermal Drug Delivery Revenue (Million US$) by Application (2016-2021)
Table 46. Global Passive Transdermal Drug Delivery Revenue Share by Application (2016-2021)
Table 47. Global Passive Transdermal Drug Delivery Price (USD/Unit) by Application (2016-2021)
Table 48. 3M Corporation Information
Table 49. 3M Description and Business Overview
Table 50. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. 3M Passive Transdermal Drug Delivery Product
Table 52. 3M Recent Developments/Updates
Table 53. Actavis, Inc. Corporation Information
Table 54. Actavis, Inc. Description and Business Overview
Table 55. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Actavis, Inc. Passive Transdermal Drug Delivery Product
Table 57. Actavis, Inc. Recent Developments/Updates
Table 58. Bayer AG Corporation Information
Table 59. Bayer AG Description and Business Overview
Table 60. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bayer AG Passive Transdermal Drug Delivery Product
Table 62. Bayer AG Recent Developments/Updates
Table 63. Boehringer Ingelheim GmbH Corporation Information
Table 64. Boehringer Ingelheim GmbH Description and Business Overview
Table 65. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product
Table 67. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 68. Corium International, Inc. Corporation Information
Table 69. Corium International, Inc. Description and Business Overview
Table 70. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Corium International, Inc. Passive Transdermal Drug Delivery Product
Table 72. Corium International, Inc. Recent Developments/Updates
Table 73. Echo Therapeutics, Inc. Corporation Information
Table 74. Echo Therapeutics, Inc. Description and Business Overview
Table 75. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product
Table 77. Echo Therapeutics, Inc. Recent Developments/Updates
Table 78. GlaxoSmithKline plc Corporation Information
Table 79. GlaxoSmithKline plc Description and Business Overview
Table 80. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product
Table 82. GlaxoSmithKline plc Recent Developments/Updates
Table 83. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
Table 84. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
Table 85. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product
Table 87. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments/Updates
Table 88. Mylan N.V. Corporation Information
Table 89. Mylan N.V. Description and Business Overview
Table 90. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Mylan N.V. Passive Transdermal Drug Delivery Product
Table 92. Mylan N.V. Recent Developments/Updates
Table 93. Novartis AG Corporation Information
Table 94. Novartis AG Description and Business Overview
Table 95. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Novartis AG Passive Transdermal Drug Delivery Product
Table 97. Novartis AG Recent Developments/Updates
Table 98. Noven Pharmaceuticals, Inc. Corporation Information
Table 99. Noven Pharmaceuticals, Inc. Description and Business Overview
Table 100. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product
Table 102. Noven Pharmaceuticals, Inc. Recent Developments/Updates
Table 103. Transdermal Corp. Corporation Information
Table 104. Transdermal Corp. Description and Business Overview
Table 105. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Transdermal Corp. Passive Transdermal Drug Delivery Product
Table 107. Transdermal Corp. Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Passive Transdermal Drug Delivery Distributors List
Table 111. Passive Transdermal Drug Delivery Customers List
Table 112. Passive Transdermal Drug Delivery Market Trends
Table 113. Passive Transdermal Drug Delivery Growth Drivers
Table 114. Passive Transdermal Drug Delivery Market Restraints
Table 115. Global Passive Transdermal Drug Delivery Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Passive Transdermal Drug Delivery Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Passive Transdermal Drug Delivery Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Passive Transdermal Drug Delivery Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Passive Transdermal Drug Delivery Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global Passive Transdermal Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Passive Transdermal Drug Delivery Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Passive Transdermal Drug Delivery Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Passive Transdermal Drug Delivery
Figure 2. Global Passive Transdermal Drug Delivery Market Share by Type in 2020 & 2027
Figure 3. Microfluidics Product Picture
Figure 4. Smart Pill Technology (SPT) Product Picture
Figure 5. Global Passive Transdermal Drug Delivery Market Share by Application in 2020 & 2027
Figure 6. Clinic
Figure 7. Hospital
Figure 8. Others
Figure 9. Global Passive Transdermal Drug Delivery Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Passive Transdermal Drug Delivery Market Size 2016-2027 (US$ Million)
Figure 11. Global Passive Transdermal Drug Delivery Sales 2016-2027 (K Units)
Figure 12. Global Passive Transdermal Drug Delivery Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Passive Transdermal Drug Delivery Sales Share by Manufacturers in 2020
Figure 14. Global Passive Transdermal Drug Delivery Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Passive Transdermal Drug Delivery Players: Market Share by Revenue in 2020
Figure 16. Passive Transdermal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Passive Transdermal Drug Delivery Sales Market Share by Region (2016-2021)
Figure 18. Global Passive Transdermal Drug Delivery Sales Market Share by Region in 2020
Figure 19. Global Passive Transdermal Drug Delivery Revenue Market Share by Region (2016-2021)
Figure 20. Global Passive Transdermal Drug Delivery Revenue Market Share by Region in 2020
Figure 21. U.S. Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Passive Transdermal Drug Delivery Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Passive Transdermal Drug Delivery by Type (2016-2021)
Figure 46. Sales Market Share of Passive Transdermal Drug Delivery by Application (2016-2021)
Figure 47. Sales Market Share of Passive Transdermal Drug Delivery by Application in 2020
Figure 48. Revenue Share of Passive Transdermal Drug Delivery by Application (2016-2021)
Figure 49. Revenue Share of Passive Transdermal Drug Delivery by Application in 2020
Figure 50. Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Figure 51. Manufacturing Process Analysis of Passive Transdermal Drug Delivery
Figure 52. Passive Transdermal Drug Delivery Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs